International consumer group slates drug companies' marketing practicesBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7557.14-b (Published 29 June 2006) Cite this as: BMJ 2006;333:14
- Michael Day
Drug companies continue to pull the wool over the eyes of patients and doctors, concludes a new report from Consumers International. The report lambasts the industry for its lack of transparency and unscrupulous marketing.
Consumers International has called on governments to rein in the industry's practices that “misinform consumers about the benefits of the drugs they are buying.”
It warns that drug companies are adopting new ways to influence consumers, such as sponsoring patients' groups and funding disease awareness campaigns, as well as using old methods such as offering hospitality to medical experts or “opinion leaders.”
Richard Lloyd, the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial